Physician profile
John J W Asheld
NPI 1699935973
$23,921.88
in general payments reported to CMS, 2019-2025
17 companies · $333 in 2025
The $333 reported for 2025 was less than what a typical Nuclear Cardiology provider received nationally (typical 2025 total: $434).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,914 · 2020: $8,477 · 2021: $3,518 · 2022: $1,089 · 2023: $351 · 2024: $240 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $905 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $905.15 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20,770.05 | 2019-2025 | Lifevest |
| Abbott Laboratories | $1,494.67 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Gallant |
| Novartis Pharmaceuticals Corporation | $360.77 | 2019-2025 | |
| Boston Scientific Corporation | $306.04 | 2021-2023 | Watchman Access System, Watchman Flx |
| Abiomed | $263.80 | 2019-2024 | Impella |
| Astellas Pharma US INC | $179.98 | 2021-2022 | |
| Edwards Lifesciences Corporation | $151.15 | 2019 | |
| Esperion Therapeutics, INC. | $109.07 | 2021 | |
| Janssen Pharmaceuticals, INC | $77.52 | 2020-2022 | |
| Kestra Medical Technology Services, INC. | $55.36 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $34.21 | 2023-2025 | Camzyos |
| Amgen INC. | $31.81 | 2025 | Repatha |
| Sanofi-Aventis U.S. LLC | $23.41 | 2022 | |
| Medtronic, INC. | $20.83 | 2025 | Symplicity G3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.85 | 2025 | Jardiance |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $17.36 | 2022 | |
| Bardy Diagnostics, INC. | $7.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Asheld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.